1.Identification
1.1GHS Product identifier
| Product name | SU 6656 |
|---|
1.2Other means of identification
| Product number | - |
|---|---|
| Other names | - |
1.3Recommended use of the chemical and restrictions on use
| Identified uses | For industry use only. |
|---|---|
| Uses advised against | no data available |
1.4Supplier's details
| Fax |
|---|
1.5Emergency phone number
| Emergency phone number | |
|---|---|
| Service hours | Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours). |
2.Hazard identification
2.1Classification of the substance or mixture
no data available
2.2GHS label elements, including precautionary statements
| Pictogram(s) | no data available |
|---|---|
| Signal word | no data available |
| Hazard statement(s) | no data available |
| Precautionary statement(s) | |
| Prevention | no data available |
| Response | no data available |
| Storage | no data available |
| Disposal | no data available |
2.3Other hazards which do not result in classification
no data available
3.Composition/information on ingredients
3.1Substances
| Chemical name | Common names and synonyms | CAS number | EC number | Concentration |
|---|---|---|---|---|
| SU 6656 | SU 6656 | 330161-87-0 | none | 100% |
4.First-aid measures
4.1Description of necessary first-aid measures
General advice
Consult a physician. Show this safety data sheet to the doctor in attendance.
If inhaled
If breathed in, move person into fresh air. If not breathing, give artificial respiration. Consult a physician.
In case of skin contact
Wash off with soap and plenty of water. Consult a physician.
In case of eye contact
Rinse thoroughly with plenty of water for at least 15 minutes and consult a physician.
If swallowed
Never give anything by mouth to an unconscious person. Rinse mouth with water. Consult a physician.
4.2Most important symptoms/effects, acute and delayed
no data available
4.3Indication of immediate medical attention and special treatment needed, if necessary
no data available
5.Fire-fighting measures
5.1Extinguishing media
Suitable extinguishing media
Use water spray, alcohol-resistant foam, dry chemical or carbon dioxide.
5.2Specific hazards arising from the chemical
no data available
5.3Special protective actions for fire-fighters
Wear self-contained breathing apparatus for firefighting if necessary.
6.Accidental release measures
6.1Personal precautions, protective equipment and emergency procedures
Use personal protective equipment. Avoid dust formation. Avoid breathing vapours, mist or gas. Ensure adequate ventilation. Evacuate personnel to safe areas. Avoid breathing dust. For personal protection see section 8.
6.2Environmental precautions
Prevent further leakage or spillage if safe to do so. Do not let product enter drains. Discharge into the environment must be avoided.
6.3Methods and materials for containment and cleaning up
Pick up and arrange disposal. Sweep up and shovel. Keep in suitable, closed containers for disposal.
7.Handling and storage
7.1Precautions for safe handling
Avoid contact with skin and eyes. Avoid formation of dust and aerosols. Avoid exposure - obtain special instructions before use.Provide appropriate exhaust ventilation at places where dust is formed. For precautions see section 2.2.
7.2Conditions for safe storage, including any incompatibilities
Store in cool place. Keep container tightly closed in a dry and well-ventilated place.
8.Exposure controls/personal protection
8.1Control parameters
Occupational Exposure limit values
no data available
Biological limit values
no data available
8.2Appropriate engineering controls
Handle in accordance with good industrial hygiene and safety practice. Wash hands before breaks and at the end of workday.
8.3Individual protection measures, such as personal protective equipment (PPE)
Eye/face protection
Safety glasses with side-shields conforming to EN166. Use equipment for eye protection tested and approved under appropriate government standards such as NIOSH (US) or EN 166(EU).
Skin protection
Wear impervious clothing. The type of protective equipment must be selected according to the concentration and amount of the dangerous substance at the specific workplace. Handle with gloves. Gloves must be inspected prior to use. Use proper glove removal technique(without touching glove's outer surface) to avoid skin contact with this product. Dispose of contaminated gloves after use in accordance with applicable laws and good laboratory practices. Wash and dry hands. The selected protective gloves have to satisfy the specifications of EU Directive 89/686/EEC and the standard EN 374 derived from it.
Respiratory protection
Wear dust mask when handling large quantities.
Thermal hazards
no data available
9.Physical and chemical properties
| Physical state | no data available |
|---|---|
| Colour | no data available |
| Odour | no data available |
| Melting point/ freezing point | no data available |
| Boiling point or initial boiling point and boiling range | no data available |
| Flammability | no data available |
| Lower and upper explosion limit / flammability limit | no data available |
| Flash point | no data available |
| Auto-ignition temperature | no data available |
| Decomposition temperature | no data available |
| pH | no data available |
| Kinematic viscosity | no data available |
| Solubility | no data available |
| Partition coefficient n-octanol/water (log value) | no data available |
| Vapour pressure | no data available |
| Density and/or relative density | 1.378g/cm3 |
| Relative vapour density | no data available |
| Particle characteristics | no data available |
10.Stability and reactivity
10.1Reactivity
no data available
10.2Chemical stability
Stable under recommended storage conditions.
10.3Possibility of hazardous reactions
no data available
10.4Conditions to avoid
no data available
10.5Incompatible materials
no data available
10.6Hazardous decomposition products
no data available
11.Toxicological information
Acute toxicity
- Oral: no data available
- Inhalation: no data available
- Dermal: no data available
Skin corrosion/irritation
no data available
Serious eye damage/irritation
no data available
Respiratory or skin sensitization
no data available
Germ cell mutagenicity
no data available
Carcinogenicity
no data available
Reproductive toxicity
no data available
STOT-single exposure
no data available
STOT-repeated exposure
no data available
Aspiration hazard
no data available
12.Ecological information
12.1Toxicity
- Toxicity to fish: no data available
- Toxicity to daphnia and other aquatic invertebrates: no data available
- Toxicity to algae: no data available
- Toxicity to microorganisms: no data available
12.2Persistence and degradability
no data available
12.3Bioaccumulative potential
no data available
12.4Mobility in soil
no data available
12.5Other adverse effects
no data available
13.Disposal considerations
13.1Disposal methods
Product
The material can be disposed of by removal to a licensed chemical destruction plant or by controlled incineration with flue gas scrubbing. Do not contaminate water, foodstuffs, feed or seed by storage or disposal. Do not discharge to sewer systems.
Contaminated packaging
Containers can be triply rinsed (or equivalent) and offered for recycling or reconditioning. Alternatively, the packaging can be punctured to make it unusable for other purposes and then be disposed of in a sanitary landfill. Controlled incineration with flue gas scrubbing is possible for combustible packaging materials.
14.Transport information
14.1UN Number
| ADR/RID: Not dangerous goods. | IMDG: Not dangerous goods. | IATA: Not dangerous goods. |
14.2UN Proper Shipping Name
| ADR/RID: unknown |
| IMDG: unknown |
| IATA: unknown |
14.3Transport hazard class(es)
| ADR/RID: Not dangerous goods. | IMDG: Not dangerous goods. | IATA: Not dangerous goods. |
14.4Packing group, if applicable
| ADR/RID: Not dangerous goods. | IMDG: Not dangerous goods. | IATA: Not dangerous goods. |
14.5Environmental hazards
| ADR/RID: no | IMDG: no | IATA: no |
14.6Special precautions for user
no data available
14.7Transport in bulk according to Annex II of MARPOL 73/78 and the IBC Code
no data available
15.Regulatory information
15.1Safety, health and environmental regulations specific for the product in question
| Chemical name | Common names and synonyms | CAS number | EC number |
|---|---|---|---|
| SU 6656 | SU 6656 | 330161-87-0 | none |
| European Inventory of Existing Commercial Chemical Substances (EINECS) | Not Listed. | ||
| EC Inventory | Not Listed. | ||
| United States Toxic Substances Control Act (TSCA) Inventory | Not Listed. | ||
| China Catalog of Hazardous chemicals 2015 | Not Listed. | ||
| New Zealand Inventory of Chemicals (NZIoC) | Not Listed. | ||
| Philippines Inventory of Chemicals and Chemical Substances (PICCS) | Not Listed. | ||
| Vietnam National Chemical Inventory | Not Listed. | ||
| Chinese Chemical Inventory of Existing Chemical Substances (China IECSC) | Not Listed. |
||
Deutsche
Español
français
italiano
português
日本語
한국어
العربية
русский
bahasa Indonesia
Tiếng Việt

Folic acid,59-30-3
MK-4827 (HCl)
Folic acid
5-Bromo-2-chloropyrimidine 32779-36-5
Niraparib
(R)-tert-butyl 3-(4-aMinophenyl)piperidine-1-carboxylate
tert-butyl 3-(4-aminophenyl)piperidine-1-carboxylate
(3S)-3-[4-[7-[[(1,1-Dimethylethyl)amino]carbonyl]-2H-indazol-2-yl]phenyl]-1-piperidinecarboxylic acid 1,1-dimethylethyl ester
(3S)-3-(4-Bromophenyl)-1-piperidinecarboxylic acid 1,1-dimethylethyl ester
3-(4-Bromophenyl)piperidine-1-carboxylic acid tert-butyl ester
3-Chloro-4-(3-fluorobenzyloxy)nitrobenzene
Niraparib p-toluenesulfonate
N-(1,1-Dimethylethyl)-2-[4-(3S)-3-piperidinylphenyl]-2H-indazole-7-carboxamide
2-{4-[(3S)-piperidin-3-yl]phenyl}-2H-indazole-7-carboxamide
Alectinib
Benzaldehyde,4-(2-methylpropoxy)
2-(4-ethyl-3-iodophenyl)-2-Methylpropanoic acid
6-cyano-2-(2-(4-ethyl-3-(4-morpholinopiperidin-1-yl)phenyl)propan-2-yl)-1H-indole-3-carboxylic acid
9-ethyl-8-iodo-6,6-diMethyl-11-oxo-6,11-dihydro-5H-benzo[b]carbazole-3-carbonitrile
6-broMo-7-Methoxy-1,1-diMethyl-3,4-dihydronaphthalen-2(1H)-one
tert-butyl 4-(4-ethyl-3-iodophenyl)-4-methyl-3-oxopentanoate
9-broMo-8-hydroxy-6,6-diMethyl-11-oxo-6,11-dihydro-5H-benzo[b]carbazole-3-carbonitrile
9-ethyl-6,6-diMethyl-8-(4-Morpholinopiperidin-1-yl)-11-oxo-5a,6,11,11a-tetrahydro-5H-benzo[b]carbazole-3-carbonitrile hydrochloride
tert-butyl 6-cyano-2-(2-(4-ethyl-3-iodophenyl)propan-2-yl)-1H-indole-3-carboxylate
ethyl 2-(4-broMophenyl)-2-Methylpropanoate
ert-Butyl (4R-cis)-6-formaldehydel-2,2-dimethyl-1,3-dioxane-4-acetate
(2S)-Hydroxy(phenyl)acetic acid (2R)-N-benzyl-1-(4-methoxyphenyl)propan-2-amine
5-Tosyladenosine
Filgotinib
3-amino-2-chloroacrolein
2-Methylpyrazolo[1,5-a]pyrimidine-6-carboxamide
11-(1-Methylpiperidin-4-ylidene)-6,11-dihydro-5H-benzo[d]iMidazo[1,2-a]azepine
1-(4-(1-PHENETHYL-1H-IMIDAZOLE-2-CARBONYL)PIPERIDIN-1-YL)ETHANONE
ethyl (3R)-5-amino-3-hydroxypentanoate,hydrochloride
LAS191954 free base
tert-butyl 5-tosyl-5H-pyrrolo[2,3-b]pyrazin-2-ylcarbamate
ABT-494 Intermeidate N-2
abt594 Intermediate
LOXO101 Intermediate 2
LOXO101 Intermediate 1
Deutetrabenazine intermediate N-2
Deutetrabenazine intermediate N-1
Naldemedine tosylate intermediate
Naldemedine tosylate intermediate N-2
Naldemedine
Eribulin
2-BroMo-1-quinolin-6-yl-ethanone
6-[(6-Bromo-1H-[1,2,3]triazolo[4,5-b]pyrazin-1-yl)methyl]-7-fluoroquinoline
tert-butyl (S)-2-((tert-butoxycarbonyl)amino)-3-(4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)propanoate
7-Trifluoromethyl-imidazo[1,2-a]pyridine
methyl 4-(aminomethyl)-3-chlorobenzoate
methyl 3-oxo-2-(trifluoromethyl)butanoate
2-AMino-4,5,6,7-tetrahydro-benzo[b]thiophene-3-carboxylic acid tert-butyl ester
Methanone, (2-aMino-5-Methoxyphenyl)(4-chlorophenyl)
benzyl 5-methyl-3-oxo-2-phenyl-2,3-dihydro-1H-pyrazole-4-carboxylate
3-(1H-pyrazol-5-yl)phenol
4-(1H-Pyrazol-3-yl)aniline
1-(5-bromo-pyridin-2-yl)-2,2-dimethyl-propan-1-ol
1-(5-bromo-pyridin-2-yl)-2-methyl-propan-1-ol
Benzenemethanol, a-[(1S)-1-aminoethyl]-4-hydroxy-,(aR)
2-{[3-(4-Fluorophenyl)-4-oxo-3,4,6,7-tetrahydrothieno[3,2-d]pyrim idin-2-yl]sulfanyl}-N-(6-methyl-1,3-benzothiazol-2-yl)acetamide
2-((3-(2-methoxyphenyl)-4-oxo-3,4,6,7-tetrahydrothieno[3,2-d]pyrimidin-2-yl)thio)-N-(6-methylbenzo[d]thiazol-2-yl)acetamide
N-(6-Methyl-2-benzothiazolyl)-2-[(3,4,6,7-tetrahydro-4-oxo-3-phenylthieno[3,2-d]pyrimidin-2-yl)thio]-acetamide
(R)-(-)-1-(4-methoxyphenyl)-2-benzylaminopropane
4(3H)-Quinazolinone,7-bromo-6-chloro-3-[3-(3-hydroxy-2-piperidinyl)-2-oxopropyl]
9-OXO-1,2,3,9-TETRAHYDRO-PYRROLO[2,1-B]QUINAZOLINE-6-CARBOXYLIC ACID
2-(2-TRIFLUOROMETHYL-PHENYL)-PYRROLIDINE
(-)-4(R)-(2-Chloro-4-fluorophenyl)-2-(3,5-difluoropyridin-2-yl)-6-methyl-1,4-dihydropyrimidine-5-carboxylic acid methyl ester
2-Butenoic acid, 2-hydroxy-4-[5-(1-Methylethyl)-2,4-bis(phenylMethoxy)phenyl]-4-oxo-, ethyl ester
ALK inhibitor 2
Cefmenoxime hydrochloride
(S)-N-1-Boc-N-4-Cbz-2-piperazinecarboxylic acid
Avermectin
L-CANAVANINE SULFATE
3-Fluoropropiophenone 455-67-4
3-Hydroxypropiophenone 13103-80-5
2-Cyano-5-chloropyrimidine 38275-56-8
N-Formylpiperidine 2591-86-8
Indazole-3-carboxylic acid 4498-67-3
5-Bromo-2-cyanopyrimidine 38275-57-9
4,4-Dibromobenzophenone 3988-03-2
1,2,3,4-Tetrahydro-benzo[b]azepin-5-one 1127-74-8
4038-14-6,(3,4-dimethoxyphenyl)-phenylmethanone 4038-14-6
2-Amino-5-bromopyrimidine 7752-82-1
Triphenylbismuth 603-33-8
3-Ethynylimidazo[1,2-a]pyridine 943320-53-4
4-Nitrophenylacetonitrile 555-21-5
2-(4-aminophenyl)acetonitrile 3544-25-0
isoxazole 288-14-2
5-Methylisoxazole 5765-44-6
3-Aminoisoxazole 1750-42-1
2-Hydroxydiphenylmethane 28994-41-4
2,5-Difluorobenzyl Cyanide 69584-87-8
2,4-Difluorophenylacetonitrile 656-35-9
2,5-Difluorophenylacetic acid 85068-27-5
2,4-Difluorophenylacetic acid 81228-09-3
3-trifluoromethylbenzoic acid 454-92-2
2-[3-(trifluoromethyl)phenyl]acetonitrile 2338-76-3
2-[3-(trifluoromethyl)phenyl]acetic acid 351-35-9
3-Chlorobenzoyl chloride 618-46-2
3-Chlorobenzaldehyde 587-04-2
3-chlorobenzoic acid 535-80-8
3-Chlorobenzyl chloride 620-20-2
3-Chlorobenzyl cyanide 1529-41-5
2-(3-chlorophenyl)acetic acid 1878-65-5
Dimethylchloroacetal 97-97-2
Chloroacetaldehyde diethyl acetal 621-62-5
2-bromo-1,1-diethoxyethane 2032-35-1
2,2-dimethoxyethanamine 22483-09-6
2,2-Diethoxyethylamine 645-36-3
2-Methylphenylacetic acid 644-36-0
3-Isochromanone 4385-35-7
2,5-Dimethylphenylacetic acid 13612-34-5
2,4-Dimethylphenylacetic Acid 6331-04-0
2,5-Dimethylphenylacetonitrile 16213-85-7
2,4-Dimethylphenylacetonitrile 68429-53-8
5-CHLORO-2-FLUOROBENZOYL CHLORIDE 394-29-6
5-Chloro-2-fluorobenzoic acid 394-30-9
2,5-Dichlorobenzaldehyde 6361-23-5
2,5-Dichlorobenzoic acid 50-79-3
2,5-DICHLOROBENZOYL CHLORIDE 2905-61-5
2,2-Azobis(2-methylpropionamidine) dihydrochloride 2997-92-4
L-Phenylalanine, 1-methylethyl ester, hydrochloride 95585-78-7
Diphenylphosphoryl azide 26386-88-9
Methyl 4-(bromomethyl)benzoate 2417-72-3
Tideglusib 865854-05-3
Disodium 7,7-(carbonyldiimino)bis(4-hydroxynaphthalene-2-sulphonate) 20324-87-2
SU 6656 330161-87-0
Saccharin 1-methylimidazole 482333-74-4
CeMMEC13 1790895-25-8
Rabusertib 911222-45-2
Salermide 1105698-15-4
EST 88321-09-9
SC79 305834-79-1
C646 328968-36-1
1-(2-bromophenyl)-3-(2-hydroxy-4-nitrophenyl)urea 182498-32-4
Dp44mT 152095-12-0
Deguelin 522-17-8
PD168393 194423-15-9
YO01027 209984-56-5
DC10539 1822358-25-7
8-OH-DPAT 78950-78-4
YU238259 1943733-16-1
Scriptaid 287383-59-9
Velpatasvir 1377049-84-7
OTX015 202590-98-5
(+)-JQ-1 1268524-70-4
(-)-JQ-1 1268524-71-5
LY 900009 209984-68-9
LY-411575 209984-57-6
(4-nitrophenyl) 4-[bis(1,3-benzodioxol-5-yl)-hydroxymethyl]piperidine-1-carboxylate 1101854-58-3
N,N-dimethyl-2-oxo-1,3-dihydroindole-5-sulfonamide 170565-89-6
5,6,11,12-tetrahydrodibenzo[1,2-b:1,2-g][8]annulene 1460-59-9
Tetraphenylmethane 630-76-2
2-chloro-6-[(2R)-2-hydroxy-3-[(2-methyl-1-naphthalen-2-ylpropan-2-yl)amino]propoxy]benzonitrile 284035-33-2
N-(2,3-dihydrobenzo[b][1,4]dioxin-6-yl)-2-methyl-1-oxo-1,2-dihydroisoquinoline-4-carboxamide 440662-09-9
N-[2-[2-(4-chlorophenyl)-1,3-thiazol-4-yl]ethyl]butanamide 932986-18-0
5-(5-(2-(3-aminopropoxy)-6-methoxyphenyl)-1H-pyrazol-3-ylamino)pyrazine-2-carbonitrile 1234015-52-1
3-Methyl-3-[(1E)-2-phenylethenyl]-3,2:5,2:5,3-quaterpyridine 1651890-44-6
3-[4-(Dimethylamino)-3-biphenylyl]-1,1-dimethylure 1469924-27-3
8-Methoxy-N,N-dipropyl-1,2,3,4-tetrahydro-2-naphthalenamine 3897-94-7
4-{4-[(4-{[3-(Acryloylamino)phenyl]amino}-5-fluoro-2-pyrimidinyl) amino]phenoxy}-N-methyl-2-pyridinecarboxamide 1202759-32-7
1,4-Dihydro-2,6-dimethyl-3-nitro-4-(2-trifluoromethylphenyl)-pyridine-5-carboxylic acid methyl ester 71145-03-4
2-[[3-[[2-(dimethylamino)phenyl]methyl]-2-pyridin-4-yl-1,3-diazinan-1-yl]methyl]-N,N-dimethylaniline 500579-04-4
CC-122 1015474-32-4
Bioymifi 1420071-30-2
N-(4-chlorophenyl)-1-(3-(furan-2-yl)benzoyl)piperidine-3-carboxamide 1443437-74-8
E-64C 76684-89-4
2-iodo-6-methoxybiphenyl 84253-78-1
pomalidomide 19171-19-8
Stearoylbenzoylmethane 58446-52-9
benzocaine 94-09-7
tranexamic acid 1197-18-8
lidocaine 137-58-6
lidocaine hydrochloride 73-78-9
Tetracaine hydrochloride 136-47-0
4-(1-phenylethyl)benzene-1,3-diol 85-27-8
Resazurin sodium salt 62758-13-8
4704-94-3 2-(HYDROXYMETHYL)-1,3-PROPANEDIOL
L-Tyrosine 60-18-4
L-Histidine 71-00-1
3,5-Bis(bromomethyl)toluene 19294-04-3
Bis(4-methylphenyl)methanol 885-77-8
5-Fluoroorotic Acid Hydrate 207291-81-4
1,3,5-Trimethyl-1H-pyrazole-4-carboxylic acid 1125-29-7
5-Amino-2-chloro-4-fluorophenol 84478-72-8
Gabapentin-lactam 64744-50-9
EP-Directory listing
2-(5-Methyl-2-phenyl-1,3-oxazol-4-yl)ethan-1-ol 103788-65-4
2-Amino-6-cyclopropylamino-9H-purine 120503-69-7
Chromic chloride hexahydrate 10060-12-5
EP-Directory listing 3